• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

pfmdr1 基因与体外青蒿素和咯萘啶敏感性在泰国恶性疟原虫分离株中的关系。

Association between the pfmdr1 gene and in vitro artemether and lumefantrine sensitivity in Thai isolates of Plasmodium falciparum.

机构信息

Department of Parasitology, Phramongkutklao College of Medicine, Bangkok, Thailand.

出版信息

Am J Trop Med Hyg. 2010 Nov;83(5):1005-9. doi: 10.4269/ajtmh.2010.10-0339.

DOI:10.4269/ajtmh.2010.10-0339
PMID:21036827
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2963959/
Abstract

We evaluated the influence of pfmdr1 mutations and copy number on in vitro artemether and lumefantrine sensitivity in 101 laboratory and adapted Thai isolates of Plasmodium falciparum. Approximately one-fourth of these isolates exhibited reduced lumefantrine susceptibility. We found that both mutations and amplification of the pfmdr1 gene influenced in vitro artemether and lumefantrine sensitivity. Using multivariate analysis, 184F or 1042N alleles and a copy number of ≥ 4 were identified as the independent markers for decreased lumefantrine susceptibility. Separate analysis also indicated that parasites from different geographical areas were influenced by different genetic markers.

摘要

我们评估了 pfmdr1 突变和拷贝数对 101 株实验室和泰国适应性疟原虫 falciparum 分离株体外青蒿素和咯萘啶敏感性的影响。大约四分之一的这些分离株显示出咯萘啶敏感性降低。我们发现 pfmdr1 基因的突变和扩增均影响青蒿素和咯萘啶的体外敏感性。多变量分析显示,184F 或 1042N 等位基因和拷贝数≥4 是咯萘啶敏感性降低的独立标志物。单独分析还表明,来自不同地理区域的寄生虫受到不同遗传标记的影响。

相似文献

1
Association between the pfmdr1 gene and in vitro artemether and lumefantrine sensitivity in Thai isolates of Plasmodium falciparum.pfmdr1 基因与体外青蒿素和咯萘啶敏感性在泰国恶性疟原虫分离株中的关系。
Am J Trop Med Hyg. 2010 Nov;83(5):1005-9. doi: 10.4269/ajtmh.2010.10-0339.
2
Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia.柬埔寨恶性疟原虫中Pfmdr1基因拷贝数与青蒿素衍生物联合疗法失败情况
Malar J. 2009 Jan 12;8:11. doi: 10.1186/1475-2875-8-11.
3
Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin.Pfmdr1在恶性疟原虫对氯喹、奎宁、单去乙基氨喹啉、甲氟喹、本芴醇和双氢青蒿素的体外易感性中的作用。
Antimicrob Agents Chemother. 2014 Dec;58(12):7032-40. doi: 10.1128/AAC.03494-14. Epub 2014 Sep 8.
4
Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania.坦桑尼亚巴加莫约地区与青蒿琥酯-咯萘啶耐药性相关的分子标志物的时间趋势。
Malar J. 2013 Mar 18;12:103. doi: 10.1186/1475-2875-12-103.
5
Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration.在青蒿素耐药性追踪合作项目中对东南亚地区恶性疟原虫多药耐药性 1(pfmdr1)和疟原虫氯喹抗性转运蛋白(pfcrt)中的抗疟耐药性标志物进行分析。
Malar J. 2016 Nov 8;15(1):541. doi: 10.1186/s12936-016-1598-6.
6
Selection of N86F184D1246 haplotype of Pfmrd1 gene by artemether-lumefantrine drug pressure on Plasmodium falciparum populations in Senegal.蒿甲醚-本芴醇药物压力对塞内加尔恶性疟原虫群体中Pfmrd1基因N86F184D1246单倍型的选择作用
Malar J. 2016 Aug 25;15(1):433. doi: 10.1186/s12936-016-1490-4.
7
Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.在利比里亚,用青蒿琥酯-阿莫地喹固定剂量复方或蒿甲醚-本芴醇治疗后恶性疟原虫pfcrt和pfmdr1基因多态性的选择
Malar J. 2016 Sep 5;15(1):452. doi: 10.1186/s12936-016-1503-3.
8
Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with pfmdr1 polymorphisms.恶性疟原虫药物耐药表型的评估方法为检测患者抗疟药物水平及其与 pfmdr1 多态性的关系。
J Infect Dis. 2013 Mar 1;207(5):842-7. doi: 10.1093/infdis/jis747. Epub 2012 Dec 5.
9
Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin.恶性疟原虫疟疾中pfmdr1拷贝数的减少会增加对甲氟喹、卤泛群、奎宁和青蒿素的易感性。
J Infect Dis. 2006 Aug 15;194(4):528-35. doi: 10.1086/507115. Epub 2006 Jul 11.
10
Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance.恶性疟原虫 ABC 转运蛋白基因的新型多态性与主要 ACT 抗疟药物耐药性相关。
PLoS One. 2011;6(5):e20212. doi: 10.1371/journal.pone.0020212. Epub 2011 May 25.

引用本文的文献

1
Changes in susceptibility of Plasmodium falciparum to antimalarial drugs in Uganda over time: 2019-2024.2019 - 2024年期间乌干达恶性疟原虫对抗疟药物敏感性的变化
Nat Commun. 2025 Aug 9;16(1):7353. doi: 10.1038/s41467-025-62810-x.
2
Influence of genetic factors of humans, mosquitoes and parasites, on the evolution of Plasmodium falciparum infections, malaria transmission and genetic control methods: a review of the literature.人类、蚊子和寄生虫的遗传因素对恶性疟原虫感染的演变、疟疾传播及遗传控制方法的影响:文献综述
BMC Med Genomics. 2025 Jun 2;18(1):100. doi: 10.1186/s12920-025-02165-w.
3
Detection of low frequency artemisinin resistance mutations, C469Y, P553L and A675V, and fixed antifolate resistance mutations in asymptomatic primary school children in Kenya.在肯尼亚无症状小学生中检测低频青蒿素抗性突变C469Y、P553L和A675V以及固定的抗叶酸抗性突变。
BMC Infect Dis. 2025 Jan 16;25(1):73. doi: 10.1186/s12879-025-10462-z.
4
Assessment of artemisinin tolerance in Plasmodium falciparum clinical isolates in children with uncomplicated malaria in Ghana.加纳单纯性疟疾患儿恶性疟原虫临床分离株对青蒿素耐受性的评估。
Malar J. 2023 Feb 19;22(1):58. doi: 10.1186/s12936-023-04482-w.
5
Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda.乌干达北部恶性疟原虫对双氢青蒿素和咯萘啶的敏感性降低。
Nat Commun. 2022 Oct 26;13(1):6353. doi: 10.1038/s41467-022-33873-x.
6
Assessing the Roles of Molecular Markers of Antimalarial Drug Resistance and the Host Pharmacogenetics in Drug-Resistant Malaria.评估抗疟药物耐药性分子标志物和宿主药物遗传学在耐药疟疾中的作用
J Trop Med. 2022 May 17;2022:3492696. doi: 10.1155/2022/3492696. eCollection 2022.
7
Polymorphism analysis of pfmdr1 gene in Plasmodium falciparum isolates 11 years post-adoption of artemisinin-based combination therapy in Saudi Arabia.沙特阿拉伯采用基于青蒿素的联合疗法 11 年后,恶性疟原虫 pfmdr1 基因的多态性分析。
Sci Rep. 2022 Jan 11;12(1):517. doi: 10.1038/s41598-021-04450-x.
8
Selection of K76 and N86 Coding Alleles after Uncomplicated Malaria Treatment by Artemether-Lumefantrine in Mali.在马里使用青蒿琥酯-咯萘啶治疗无并发症疟疾后 K76 和 N86 编码等位基因的选择。
Int J Mol Sci. 2021 Jun 3;22(11):6057. doi: 10.3390/ijms22116057.
9
Balanced impacts of fitness and drug pressure on the evolution of PfMDR1 polymorphisms in Plasmodium falciparum.适应性和药物压力对恶性疟原虫PfMDR1多态性进化的平衡影响。
Malar J. 2021 Jun 30;20(1):292. doi: 10.1186/s12936-021-03823-x.
10
Tolerance of Gambian Plasmodium falciparum to Dihydroartemisinin and Lumefantrine Detected by Parasite Survival Rate Assay.寄生虫存活率检测法发现冈比亚疟原虫对双氢青蒿素和咯萘啶的耐受性。
Antimicrob Agents Chemother. 2020 Dec 16;65(1). doi: 10.1128/AAC.00720-20.

本文引用的文献

1
Multiple genetic backgrounds of the amplified Plasmodium falciparum multidrug resistance (pfmdr1) gene and selective sweep of 184F mutation in Cambodia.柬埔寨恶性疟原虫多药耐药基因(pfmdr1)扩增的多种遗传背景和 184F 突变的选择清除。
J Infect Dis. 2010 May 15;201(10):1551-60. doi: 10.1086/651949.
2
Role of pfmdr1 amplification and expression in induction of resistance to artemisinin derivatives in Plasmodium falciparum.疟原虫 falciparum 中 pfmdr1 扩增和表达在诱导对青蒿素衍生物耐药中的作用。
Antimicrob Agents Chemother. 2010 Jun;54(6):2455-64. doi: 10.1128/AAC.00947-09. Epub 2010 Mar 29.
3
High heritability of malaria parasite clearance rate indicates a genetic basis for artemisinin resistance in western Cambodia.高疟原虫清除率的遗传力表明柬埔寨西部青蒿素耐药性存在遗传基础。
J Infect Dis. 2010 May 1;201(9):1326-30. doi: 10.1086/651562.
4
Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.在布基纳法索,青蒿琥酯-咯萘啶和阿莫地喹-磺胺多辛-乙胺嘧啶选择已知的疟原虫耐药相关多态性,但二氢青蒿素-哌喹没有。
Antimicrob Agents Chemother. 2010 May;54(5):1949-54. doi: 10.1128/AAC.01413-09. Epub 2010 Mar 15.
5
In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1.在肯尼亚恶性疟原虫分离株中哌喹、青蒿琥酯和二氢青蒿素的体外活性以及 pfcrt 和 pfmdr1 的多态性。
Antimicrob Agents Chemother. 2009 Dec;53(12):5069-73. doi: 10.1128/AAC.00638-09. Epub 2009 Sep 21.
6
Artemisinin resistance in Plasmodium falciparum malaria.恶性疟原虫疟疾中的青蒿素耐药性。
N Engl J Med. 2009 Jul 30;361(5):455-67. doi: 10.1056/NEJMoa0808859.
7
The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa.pfmdr1在非洲恶性疟原虫对蒿甲醚-本芴醇耐受性中的作用。
Trop Med Int Health. 2007 Jun;12(6):736-42. doi: 10.1111/j.1365-3156.2007.01843.x.
8
Recurrent gene amplification and soft selective sweeps during evolution of multidrug resistance in malaria parasites.疟原虫多药耐药性进化过程中的反复基因扩增和软选择性清除
Mol Biol Evol. 2007 Feb;24(2):562-73. doi: 10.1093/molbev/msl185. Epub 2006 Nov 23.
9
Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin.恶性疟原虫疟疾中pfmdr1拷贝数的减少会增加对甲氟喹、卤泛群、奎宁和青蒿素的易感性。
J Infect Dis. 2006 Aug 15;194(4):528-35. doi: 10.1086/507115. Epub 2006 Jul 11.
10
Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria.耐多药恶性疟原虫疟疾对蒿甲醚-本芴醇治疗反应的分子和药理学决定因素
Clin Infect Dis. 2006 Jun 1;42(11):1570-7. doi: 10.1086/503423. Epub 2006 Apr 26.